
According to Jessica Liu, patients with BRVO or CRVO with any lapse in treatment of 3 months or longer are at risk for poorer outcomes.

According to Jessica Liu, patients with BRVO or CRVO with any lapse in treatment of 3 months or longer are at risk for poorer outcomes.

Investigators found that non-invasive ocular blood flow measurement using laser speckle flowgraphy may be a new indicator of shock-related organ damage.

Investigators review changes in ocular anterior segment blood flow and temperature after treatment of patients with meibomian gland dysfunction.

Seth Miller, clinical operations manager at Ora Inc., discusses the relationship between the symptoms of dry eye and aging, based on his ARVO 2021 presentation.

Jeffrey Gemi, MD, Ora Inc., speaks on the highlights from his presentation comparing Schirmer's test with other clinical outcomes in dry eye.

‘Revolutionary Eye and Vision Research’ theme of annual meeting.

Study points to possible role of addressing preprocedural anxiety

Large randomized trial compares efficacy and safety of multiple regimens



For the first time ever, the Association for Research in Vision and Ophthalmology (ARVO) is taking its annual meeting outside the United States, heading north of the border to Vancouver, British Columbia.

Group offering ARVOLearn educational platform; AI focus of upcoming online session